StonvexLoading…
StonvexStonvexStonvexCore line items from LOT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $519.10M | $924.35M | $679.01M | $9.56M |
Operating Income | $-423.20M | $-786.32M | $-735.94M | $-687.41M |
Net Income | $-464.22M | $-1.10B | $-742.00M | $-723.92M |
EPS (Diluted) | $-0.72 | $-1.72 | $-1.60 | $-1.52 |
Total Assets | $1.95B | $2.29B | $1.58B | $1.37B |
Total Liabilities | $3.28B | $3.15B | $2.41B | $1.46B |
Cash & Equivalents | $73.43M | $103.07M | $418.94M | $736.61M |
Free Cash Flow OCF − CapEx | $-413.34M | $-905.86M | $-600.65M | $-484.76M |
Shares Outstanding | 640.67M | 676.83M | 474.62M | 474.62M |